CSIMarket Company Name, Ticker, Suppliers, else..


Procyon Corporation  (PCYN)
Other Ticker:  
 

Procyon Corporation

PCYN's Fundamental analysis



Looking into Procyon growth rates, revenue grew by 17.51 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 769

Major Pharmaceutical Preparations industry recorded growth of revenues by 5.18 %

Procyon's net income grew by 1159.27 % in IV. Quarter 2024 year on year, above company average,

• More on PCYN's Growth


Procyon
realized a net loss in trailing twelve months.

Procyon realized cash reduction of $ -0.02 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.3.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


• More on PCYN's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 10.28
 Tangible Book Value (Per Share $) 0.29

Procyon
realized net loss in trailing twelve months.

Procyon realized cash outflow of $ -0.02per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.3.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.

Procyon Price to Book Ratio is at 0.65 lower than Industry Avg. of 79.76. and higher than S&P 500 Avg. of 0.01

• More on PCYN's Valuation

•  Market Capitalization (Millions $) 1
•  Shares Outstanding (Millions) 8
•  Employees -
•  Revenues (TTM) (Millions $) 5
•  Net Income (TTM) (Millions $) 0
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 10.28
•  Tangible Book Value (Per Share $) 0.29

•  Market Capitalization (Millions $) 1
•  Shares Outstanding (Millions) 8
•  Employees -
•  Revenues (TTM) (Millions $) 5
•  Net Income (TTM) (Millions $) 0
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -


    PCYN's Profitability Comparisons
Procyon achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 0.63 %.

Procyon net profit margin of 6.68 % is currently ranking no. 49 in Major Pharmaceutical Preparations industry, ranking no. 133 in Healthcare sector and number 1667 in S&P 500.





  Ratio
•   Capital Ratio (MRQ) 3.08
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.4
•  Asset Turnover Ratio (TTM) 1.53
•  Inventory Turnover Ratio (TTM) 2.06



Procyon achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 0.63 %.

Procyon net profit margin of 6.68 % is currently ranking no. 49 in Major Pharmaceutical Preparations industry, ranking no. 133 in Healthcare sector and number 1667 in S&P 500.

• More on PCYN's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com